Beyond The Roundup | How Research Centers are Surviving COVID-19

Beyond the roundup

Well-known clinical trials challenges, such as delayed start-up, subpar recruitment/enrollment, and technology silos, have been exacerbated by the COVID-19 pandemic. The U.S. is among the top 10 countries with the highest COVID-19 deaths per capita and by case count1. Certain states have had to deal with natural disasters, such as wildfires and hurricanes, or civil unrest and/or mass violence while also being in a COVID-19 hotspot. To address the financial loss hospitals have encountered as a result of COVID, hundreds of hospitals furloughed workers2. and many of these have already brought back furloughed employees3. These hospitals include regional hospitals, hospital networks and academic medical centers (AMCs). Research centers are now operating in the new normal – inclusive of virtual visits, new safety measures, work-from-home, remote monitoring, and providing greater access to clinical data. What strategies did research centers implement to promote financial sustainability given financial pressures and exacerbation of old problems? In this video, we discuss.

This is sponsored content.